Cancer

Views & Analysis

At ESMO 2022, oncologists saw exciting cancer advances

Lung, breast, and non-prostate genitourinary (NGU) cancer treatments were the most exciting tracks due to the march towards personalised medicine and expanded immunotherapy options.

Events

Partner Content

6th Antifibrotic Drug Development Summit

Only cross-disease, cross-organ fibrosis summit

Oncology

Understanding the tumour micro-environment – the pharmaphoru...

As our understanding of oncology has increased, it’s become clear that each cancer consists of much more than just the tumour cell – a whole ecosystem of vessels, immune cells, and connective tissu

Views & Analysis

How data is crucial to the relaunch of the Cancer Moonshot

In this article, Ben Hargreaves takes a look at the renewed effort to tackle deaths from cancer in the US through the Cancer Moonshot.

Views & Analysis

AI diagnostics tools and oncology: predicting patient outcom...

AI French-American biotech start-up Owkin recently published new research in

Events

Partner Content

8th annual World Cancer Series Europe

The Economist’s 8th Annual World Cancer Series: Europe convenes a wide range of stakeholders critical to effective cancer care, to drive innovation, equity and excellence

At ESMO 2022, oncologists saw exciting cancer advances

6th Antifibrotic Drug Development Summit

Understanding the tumour micro-environment – the pharmaphoru...

How data is crucial to the relaunch of the Cancer Moonshot

AI diagnostics tools and oncology: predicting patient outcom...

8th annual World Cancer Series Europe

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Cancer

Editor's Picks